BIOMAT Database Logo BIOMAT Database Logo

Revealing the drug-resistant mechanism for diarylpyrimidine analogue inhibitors of HIV-1 reverse transcriptase. 2011

Hao Zhang, and Fang Qin, and Wei Ye, and Zeng Li, and Songyao Ma, and Yan Xia, and Yi Jiang, and Jiayi Zhu, and Yixue Li, and Jian Zhang, and Hai-Feng Chen
State Key Laboratory of Microbial Metabolism, Department of Bioinformatics and Biostatistics, College of Life Science and Biotechnology, Shanghai Jiaotong University, 800 Dongchuan Road, Shanghai 200240, China.

Diaryltriazine (DATA) and diarylpyrimidine (DAPY) were two category inhibitors with highly potent activity for wild type (wt) and four principal mutant types (L100I, K103N, Y181C and Y188L) of HIV-1 reverse transcriptase (RT). We had revealed the drug-resistant mechanism of DATA analogue inhibitors with molecular dynamics simulation and three-dimensional quantitative structure-activity relationship (3D-QSAR) methods. In this work, we investigated the drug-resistant mechanism of DAPY analogue inhibitors. It was found that DAPY analogue inhibitors form more hydrogen bonds and hydrophobic contacts with wild type and mutants of HIV-1 RT than DATA inhibitors. This could explain that DAPY analogue inhibitors are more potent than DATA for the wild type and mutants of HIV-1 RT. Then, 3D-QSAR models were constructed for these inhibitors of wild type and four principal mutant types HIV-1 RT and evaluated by test set compounds. These combined models can be used to design new chemical entities and make quantitative prediction of the bioactivities for HIV-1 RT inhibitors before resorting to in vitro and in vivo experiment.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D056004 Molecular Dynamics Simulation A computer simulation developed to study the motion of molecules over a period of time. Molecular Dynamics Simulations,Molecular Dynamics,Dynamic, Molecular,Dynamics Simulation, Molecular,Dynamics Simulations, Molecular,Dynamics, Molecular,Molecular Dynamic,Simulation, Molecular Dynamics,Simulations, Molecular Dynamics
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV
D021281 Quantitative Structure-Activity Relationship A quantitative prediction of the biological, ecotoxicological or pharmaceutical activity of a molecule. It is based upon structure and activity information gathered from a series of similar compounds. Structure Activity Relationship, Quantitative,3D-QSAR,QSAR,QSPR Modeling,Quantitative Structure Property Relationship,3D QSAR,3D-QSARs,Modeling, QSPR,Quantitative Structure Activity Relationship,Quantitative Structure-Activity Relationships,Relationship, Quantitative Structure-Activity,Relationships, Quantitative Structure-Activity,Structure-Activity Relationship, Quantitative,Structure-Activity Relationships, Quantitative

Related Publications

Hao Zhang, and Fang Qin, and Wei Ye, and Zeng Li, and Songyao Ma, and Yan Xia, and Yi Jiang, and Jiayi Zhu, and Yixue Li, and Jian Zhang, and Hai-Feng Chen
2D and 3D QSAR studies of diarylpyrimidine HIV-1 reverse transcriptase inhibitors.
November 2008, Journal of computer-aided molecular design,
Hao Zhang, and Fang Qin, and Wei Ye, and Zeng Li, and Songyao Ma, and Yan Xia, and Yi Jiang, and Jiayi Zhu, and Yixue Li, and Jian Zhang, and Hai-Feng Chen
Novel diarylpyrimidine subtypes as HIV-1 nonnucleoside reverse transcriptase inhibitors with improved resistance profile.
March 2024, Journal of medical virology,
Hao Zhang, and Fang Qin, and Wei Ye, and Zeng Li, and Songyao Ma, and Yan Xia, and Yi Jiang, and Jiayi Zhu, and Yixue Li, and Jian Zhang, and Hai-Feng Chen
Identification of insertion mutations in HIV-1 reverse transcriptase causing multiple drug resistance to nucleoside analogue reverse transcriptase inhibitors.
January 1999, Journal of human virology,
Hao Zhang, and Fang Qin, and Wei Ye, and Zeng Li, and Songyao Ma, and Yan Xia, and Yi Jiang, and Jiayi Zhu, and Yixue Li, and Jian Zhang, and Hai-Feng Chen
Identification of Boronate-Containing Diarylpyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors.
November 2022, Molecules (Basel, Switzerland),
Hao Zhang, and Fang Qin, and Wei Ye, and Zeng Li, and Songyao Ma, and Yan Xia, and Yi Jiang, and Jiayi Zhu, and Yixue Li, and Jian Zhang, and Hai-Feng Chen
Discovery of diarylpyrimidine derivatives bearing piperazine sulfonyl as potent HIV-1 nonnucleoside reverse transcriptase inhibitors.
April 2023, Communications chemistry,
Hao Zhang, and Fang Qin, and Wei Ye, and Zeng Li, and Songyao Ma, and Yan Xia, and Yi Jiang, and Jiayi Zhu, and Yixue Li, and Jian Zhang, and Hai-Feng Chen
Multi-drug resistant HIV-1 reverse transcriptase genotype in children treated with dual nucleoside reverse transcriptase inhibitors (NRTIs).
October 2006, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
Hao Zhang, and Fang Qin, and Wei Ye, and Zeng Li, and Songyao Ma, and Yan Xia, and Yi Jiang, and Jiayi Zhu, and Yixue Li, and Jian Zhang, and Hai-Feng Chen
HIV-1 reverse transcriptase inhibitors.
June 2007, Applied microbiology and biotechnology,
Hao Zhang, and Fang Qin, and Wei Ye, and Zeng Li, and Songyao Ma, and Yan Xia, and Yi Jiang, and Jiayi Zhu, and Yixue Li, and Jian Zhang, and Hai-Feng Chen
Aptamers that recognize drug-resistant HIV-1 reverse transcriptase.
December 2008, Nucleic acids research,
Hao Zhang, and Fang Qin, and Wei Ye, and Zeng Li, and Songyao Ma, and Yan Xia, and Yi Jiang, and Jiayi Zhu, and Yixue Li, and Jian Zhang, and Hai-Feng Chen
Mechanisms of resistance to nucleoside analogue inhibitors of HIV-1 reverse transcriptase.
June 2008, Virus research,
Hao Zhang, and Fang Qin, and Wei Ye, and Zeng Li, and Songyao Ma, and Yan Xia, and Yi Jiang, and Jiayi Zhu, and Yixue Li, and Jian Zhang, and Hai-Feng Chen
Inhibitors of HIV-1 reverse transcriptase.
January 2008, Advances in pharmacology (San Diego, Calif.),
Copied contents to your clipboard!